rs1057519848, EGFR

N. diseases: 72
Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Non-Small Cell Lung Carcinoma
CUI: C0007131
Disease: Non-Small Cell Lung Carcinoma
712 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.800 0.983 176 2004 2020
Neoplasms
CUI: C0027651
Disease: Neoplasms
1644 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.100 0.933 60 2009 2019
Adenocarcinoma of lung (disorder)
CUI: C0152013
Disease: Adenocarcinoma of lung (disorder)
563 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.100 1.000 58 2005 2020
Malignant neoplasm of lung
CUI: C0242379
Disease: Malignant neoplasm of lung
1142 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.100 0.975 40 2005 2019
Adenocarcinoma
CUI: C0001418
Disease: Adenocarcinoma
168 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.100 0.941 34 2005 2020
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
1204 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.100 0.968 31 2006 2019
Primary malignant neoplasm of lung
CUI: C1306460
Disease: Primary malignant neoplasm of lung
981 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.100 0.968 31 2006 2019
Metastatic non-small cell lung cancer
11 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.100 1.000 12 2013 2019
Lung Neoplasms
CUI: C0024121
Disease: Lung Neoplasms
39 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.060 1.000 6 2012 2019
Metastatic malignant neoplasm to brain
28 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.050 1.000 5 2010 2018
Adenocarcinoma of lung, stage IV
CUI: C0854988
Disease: Adenocarcinoma of lung, stage IV
6 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.040 1.000 4 2013 2019
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
1641 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.040 1.000 4 2009 2017
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA
5 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.040 1.000 4 2012 2017
Neoplasm Metastasis
CUI: C0027627
Disease: Neoplasm Metastasis
327 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.040 1.000 4 2012 2018
Progressive cGVHD
CUI: C3539781
Disease: Progressive cGVHD
40 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.040 1.000 4 2011 2019
Progressive Neoplastic Disease
CUI: C0677932
Disease: Progressive Neoplastic Disease
40 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.040 1.000 4 2011 2019
Squamous cell carcinoma
CUI: C0007137
Disease: Squamous cell carcinoma
257 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.040 1.000 4 2013 2016
Carcinogenesis
CUI: C0596263
Disease: Carcinogenesis
355 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.030 0.667 3 2012 2016
Metastatic Lung Adenocarcinoma
CUI: C4744444
Disease: Metastatic Lung Adenocarcinoma
10 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.030 1.000 3 2014 2018
Metastatic Malignant Neoplasm to the Leptomeninges
9 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.030 1.000 3 2009 2019
Pleural Effusion, Malignant
CUI: C0080032
Disease: Pleural Effusion, Malignant
6 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.030 1.000 3 2011 2015
Primary malignant neoplasm
CUI: C1306459
Disease: Primary malignant neoplasm
1374 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.030 1.000 3 2012 2017
Small cell carcinoma of lung
CUI: C0149925
Disease: Small cell carcinoma of lung
125 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.030 1.000 3 2007 2013
Adenocarcinoma, Tubular
CUI: C0205645
Disease: Adenocarcinoma, Tubular
3 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.020 1.000 2 2007 2018
Breast Carcinoma
CUI: C0678222
Disease: Breast Carcinoma
2793 0.570 0.560 7 55191822 missense variant TG/GT mnv 0.020 1.000 2 2013 2015